An evaluation of pelvic organ prolapses in perimenopausal and menopausal Chinese females
J.-F. Shi, W.-Z. Xu, H.-F. Wang, W.-K. Tao, Y.-X. Ren, T. Zhang, X. Yu
Department of Obstetrics and Gynecology, Dali University, Dali, Yunnan, China. fcksjf@outlook.com
OBJECTIVE: The aim of the study was to evaluate the prevalence of pelvic organ prolapse (POP) and correlate the various factors including, but not limited to, educational status, socio-economic condition, body mass index (BMI), menstrual history, with the status and severity of POP.
PATIENTS AND METHODS: A retrospective cross-sectional study was conducted between August 2021 and September 2022 and suspected patients of POP were considered from the outpatient Department of Gynecology and Obstetrics. The study has mainly used 3 indicators of socio-economic status, namely, occupation, education, and income. These factors were correlated and statistically analyzed with that of POP.
RESULTS: The study findings revealed that there are more symptomatic patients who are illiterate as compared to asymptomatic POP and with increasing education status, there is a decrease in symptomatic POP patients (p<0.05). Also, there is a significant proportion of symptomatic POP patients in the lower class and lower middle class as compared to asymptomatic patients in each class, respectively (p<0.05). It also found that micturition difficulty and vaginal bulging are significantly correlated with the stages of POP (p<0.05).
CONCLUSIONS: Educational status and socio-economic condition are significant indicators of the presence of symptoms or severity of POP. The study further concluded that menopausal females have more symptomatic POP as compared to pre-menopausal females.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J.-F. Shi, W.-Z. Xu, H.-F. Wang, W.-K. Tao, Y.-X. Ren, T. Zhang, X. Yu
An evaluation of pelvic organ prolapses in perimenopausal and menopausal Chinese females
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 9
Pages: 3914-3921
DOI: 10.26355/eurrev_202305_32297